Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Digital health funding and deals roundup

Proscia
By Author Proscia | June 17, 2022

Proscia, an AI-enabled cancer diagnosis and research company, raised $37 million in a Series C funding round to increase the adoption of computation pathology and increase scale.  This round increases the company’s total funding to $72 million.

Our website uses cookies. By using this site, you agree to its use of cookies.